Cargando…
Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
Head and neck squamous cell carcinoma (HNSCC) is a type of tumour with a relatively poor prognosis. In recent years, immune checkpoint inhibitors, such as CTLA-4 and PD-1/PDL-1 inhibitors, have improved the treatment status of advanced tumours. However, the emergence of drug resistance has brought d...
Autores principales: | Zhang, Yaoting, Kadasah, Sultan, Xie, Jiaheng, Gu, Dongsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061055/ https://www.ncbi.nlm.nih.gov/pubmed/35510041 http://dx.doi.org/10.1155/2022/3051907 |
Ejemplares similares
-
Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma
por: Zhang, Yaoting, et al.
Publicado: (2022) -
NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment
por: Chen, Xue-min, et al.
Publicado: (2022) -
FDCSP Is an Immune-Associated Prognostic Biomarker in HPV-Positive Head and Neck Squamous Carcinoma
por: Wu, Qingqing, et al.
Publicado: (2022) -
Cuproptosis combines immune landscape providing prognostic biomarker in head and neck squamous carcinoma
por: Shu, Tingting, et al.
Publicado: (2023) -
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
por: Müller, Tim, et al.
Publicado: (2017)